Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06397885 · ClinicalTrials.gov registry record
Prospective on Market Patient-reported Outcomes for Milli
A clinical trial of Dyspareunia and Vaginismus, sponsored by Materna Medical.
- Active
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT06397885 is a study of Dyspareunia and Vaginismus that is active but no longer recruiting, run by Materna Medical. The registered enrollment target is 200 participants, above the 53-participant average among 10 other Dyspareunia trials with a reported enrollment target (277% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06397885, a study of Dyspareunia and Vaginismus, is active but no longer recruiting, sponsored by Materna Medical.
- ACTIVE NOT RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
To assess the effectiveness of the Milli device in achieving vaginal intercourse
Conditions Studied
Interventions
- DEVICE Milli Vaginal Dilator
Study Locations (1)
California
- Materna Clinic - Mountain View
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-05-12 |
| Est. Completion | 2025-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06397885
The ClinicalTrials.gov registry entry for NCT06397885 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 53-participant average among 10 other Dyspareunia trials with a reported enrollment target (277% higher). The listed sponsor is Materna Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Dyspareunia appearing as the primary indexed condition, and to 1 intervention - of which Milli Vaginal Dilator is the first listed.
NCT06397885 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06397885 about?
NCT06397885 is a clinical study titled "Prospective on Market Patient-reported Outcomes for Milli". To assess the effectiveness of the Milli device in achieving vaginal intercourse
What is the current status of trial NCT06397885?
This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2024-05-12. Estimated completion is 2025-12-30.
What conditions does trial NCT06397885 study?
This clinical trial studies the following conditions: Dyspareunia, Vaginismus.
What interventions are being tested in trial NCT06397885?
The interventions under investigation include: Milli Vaginal Dilator (DEVICE).
Who is sponsoring clinical trial NCT06397885?
This trial is sponsored by Materna Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06397885 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dyspareunia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy
RECRUITING · NA
-
VIBRating vs Traditional Therapy for Treatment of ENTry Dyspareunia
RECRUITING · NA
-
Fractional CO2 Laser Therapy for Survivors of Breast Malignancies
COMPLETED · NA
-
Acupuncture for Vulvodynia: A Pre-pilot Study
COMPLETED · NA
-
Acupuncture for the Treatment of Vulvodynia
COMPLETED · NA
-
Changes to Vulva, Vestibule, Urethral Meatus and Vagina 20 Weeks Post Daily Prasterone in Women With Dyspareunia
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.